RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
Thromb Haemost 1998; 80(02): 349-350
DOI: 10.1055/s-0037-1615206
DOI: 10.1055/s-0037-1615206
Letters to the Editor
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants (LA)
Weitere Informationen
Publikationsverlauf
Received
23. Januar 1998
Accepted after revision
02. April 1998
Publikationsdatum:
08. Dezember 2017 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/199802/lookinside/thumbnails/10-1055-s-0037-1615206-1.jpg)
-
References
- 1 Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants.. Ann Int Med 1998; 127: 177-85.
- 2 Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.. Brit J Haematol 1998; 98: 887-92.
- 3 Della Valle P, Crippa L, Safa O, Tomassini L, Pattarini E, Vigano’-D’Angelo S, Sabbadini MG, D’Angelo A. Potential failure on the International Normalized Ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants.. Ann Med Interne 1996; 147 (Suppl. 01) 10-4.
- 4 WHO Expert Committee on Biological Standardization.. Guidelines for thromboplastin and plasma used to control oral anticoagulant therapy.. To be published. Technical Report Series 1998.